Access cutting-edge transthyretin cardiac amyloidosis treatment through this clinical trial at a research site in Evanston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Evanston location
Preparing your pre-screening questions…
Access transthyretin cardiac amyloidosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related transthyretin cardiac amyloidosis treatment provided free
Check if you qualify for this transthyretin cardiac amyloidosis clinical trial in Evanston, IL
No-Cost Study Care
Local to Evanston
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
CONCERTO is a retrospective, observational, multicentric and single-arm study to perform an external validation of the cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, to detect Transthyretin cardiac amyloidosis (ATTR-CA). Thus, this study will assess Willem™ ability to distinguish between truly diagnosed ATTR-CA patients and confirmed non-ATTR-CA patients from ECG data.
Sponsor: Idoven 1903 S.L.
Yes, this clinical trial (NCT06978660) has an active research site in Evanston, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for transthyretin cardiac amyloidosis treatment options in Evanston, IL, this clinical trial (NCT06978660) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Evanston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced transthyretin cardiac amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all transthyretin cardiac amyloidosis clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Evanston — not just this study.
Browse Essential Tremor Trials in Evanston →